RSS

Issue 18.2

Dr Andrew Rut, CEO and founder of MyMeds&Me, examines the critical role of new technology, in the form of smart pharmaceuticals and blockchain, in advancing patient autonomy and drug development. more

Opinion

In this article, Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon, Arthur D. Little, introduce a framework to guide analogue-native companies in the use of levers to manage the transition to digital. more

, , , Opinion

As a new era of digital drug delivery is making headway, Dr Steven Wick, vice president, Product Development & Commercialisation, 3M Drug Delivery Systems, gives us his thoughts on this digital future. more

Opinion

In this feature, Medicom, a Phillips-Medisize company, looks at the potential of smart devices & connected health services within the pharma sector and how companies can use already available technologies to make the transition as smooth as possible more

, Opinion

According to Bhaskar Sambasivan, SVP and global markets leader, Life Sciences at Cognizant, digital systems need to evolve in order for the UK’s life sciences industry to flourish. Here, he tells us more… more

Opinion

Despite the ongoing trend in digital tech across the board, pharma is still lagging behind in unlocking the potential of these useful tools… more

Opinion

The team behind PuroVaso saw an opportunity to design an entirely new solution for moving and storing that was better suited to modern manufacturing processes. Here, they tell us more… more

Opinion

More and more newer drugs contain high potency active pharmaceutical ingredients (APIs), which require careful handling and specialised equipment. Here, Precision Polymer Engineering (PPE) highlights why split butterfly valves offer a cost-effective more

Opinion

In this article, Michael Avraam, global product manager at ChargePoint Technology discusses the potential issues with containment performance testing some techniques and developments that may help to ensure efficiency more

Opinion

As the manufacture of biologics takes on increased significance in the pharmaceutical sector, it’s clear to see why GE Healthcare’s KUBio system is growing in popularity. Lu Rahman paid a visit to the company facility in Uppsala to find out more… more

Opinion

Here, Dale Pittock, sales director of pharmacy packaging provider Valley Northern, explains how contract packaging can support pharmaceutical innovation. more

Opinion

In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D. more

, Opinion

There is rising tide of drug-resistant microbes that is thought of as one of the greatest threats to public health today, yet the pipeline of new antibiotics is dwindling. Here, Dr Peter Jackson, AMR Centre, discusses what action is needed more

Opinion

We speak with the CEO of Controlant, Gisli Herjolfsson, about the company and its cold chain solutions that are revolutionising delivery of vaccines to developing countries and more. more

Opinion

Scott Allison, president, Life Sciences & Healthcare Sector, DHL, gives us a rundown of the connected warehouse and how innovations in logistics are benefitting this rapidly changing world. more

Opinion

Glenn Thorpe, senior vice president sales, Datwyler, looks at why the US is a strong pillar of pharmaceutical manufacturing. more

Opinion

As pharma encounters massive shifts in public perception, which is seemingly negative in the current climate, Nick Johns from ConsumerSafety.org, looks at the focus of pharma in the US and how shifting this could benefit public perception more

Opinion

Here, Dr Neil Polwart, Novarum founder and BBI group head of mobile, goes into greater detail about how digital technologies will herald a new era for pharma. more

Opinion

With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders more

Opinion